Hormone Replacement Therapy drugs were often prescribed for patients as they aged and began going through menopause. The drug is a progestin that combines estrogen and medroxyprogesterone acetate, which can cause serious and debilitating side effects. Studies show that the combination often increases the risk of breast and ovarian cancer.
When ovaries stop making estrogen, menopause begins for women between 45-55 years old, and signals the end of the menstral cycle, often referred to the "change of life".
More than 3 million women in the US took HR drugs daily to replace the hormones lost during menopause. Each woman is affected differently by menopause. Some breeze right through it with little or no problems, and others experience hot flashes, night sweats, mood swings, vaginal atrophy, vaginal itch, irregular menstruation, and other problems.
For these situations, Hormone Replacement Therapy was prescribed to reduce these symptoms, and the possibility of osteoporosis and heart disease.
Hormone Replacement Therapy was approved by the (Federal Drug Administration) for use in 1995. It has been found however, that there are dangerous side effects with long term use, such as breast cancer, and ovarian cancer, and many lawsuits have been filed across the US because of side effects.
The manufacturer is responsible for the predominance of the side-effects of it and the injuries being pursued in HR litigation. Menopausal and postmenopausal women were erroneously and repeatedly over prescribed by their doctors indicating that HRT should be taken indefinitely. Inappropriate labeling failed to fully describe the side-effects and long-term dosage has created many serious and life threatening health risks for women. It is the responsibility of drug manufacturers to protect women from harmful injury and to warn users of the side effects of HR drugs.
Because of this failure by manufacturers, many lawsuits have been filed against the manufactures, and are currently in litigation. HRT litigation began after an article published in the Journal of the American Medical Association, (AMA), stated that side effects of HRT increased the risk of possible dementia in postmenopausal women 65 years or older.
Lawsuit loans (advances) may be available for litigants awaiting the outcome of these cases. Investors will often advance cash on the potential recovery in a HR litigation case. If you know of a person that was injured by taking HR, their case may qualify to get a "non recourse" advance on their lawsuit while their case goes through the court system. "Non recourse" means that the loan (advance) is paid back to the investor, along with interest and fees, only, when there is a successful recovery in the case. If the case doesn't settle successfully or the recovery isn't sufficient enough to cover the advance, the advance is never repaid. Lawsuit Funding investors advance cash on many types of pending lawsuits, such as Personal Injury, Medical Device and Drug Related Cases, Malpractice, Jones Act (seamans claims), Railroad (FELA) Workers Comp (in some states), Workers Comp Third Party, Auto Accidents, Slip/Trip/Falls. Premises Liability, & Product Liability. Other cases that we often do are Commercial Litigation, Breach of Contract, Wrongful Death, Wrongful Imprisonment, Wrongful Termination, Insurance Bad Faith, Expert Witness Funding, Attorney/Law firm Funding, & Settled Case Funding, and others. Types of cases that qualify vary with each company, so be sure to check if a particular company does your type of funding. Rates and fees also vary from company to company.
Your blog is very nice I really like it. Contact Top Notch Funding immediately for very low-cost litigation funding.
ReplyDelete